Medifast (MED) Misses Q4 EPS by 120c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.56 -0.55%
EPS Growth %: -195.2%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -195.2%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of ($1.65), $1.20 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $75.1 million versus the consensus estimate of $73.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Mizuho Defends Sarepta Therapeutics (SRPT)
- Hyperion DeFi, Inc. (HYPD) PT Raised to $8.45 at Chardan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
